Post by
Siberia on Jan 02, 2022 10:55pm
✅Rob Fia, CEO of Therma Bright-Documents Submitted
(A few weeks are gone). November 12, 2021. Based on current COVID-19 infection rates, we expect the study results to be delivered to the FDA within the next few weeks, as part of our AcuVid application for Emergency Use Authorization (EUA). More info at: https://themarketherald.ca/therma-bright-to-begin-acuvidtm-u-s-clinical-performance-study-with-receipt-of-irb-conditional-approval-2021-11-12/
Comment by
Commoncents on Jan 03, 2022 7:56am
Yes. And as of December 29, the clinical study wasn't complete. I'm a shareholder guys. Why do you insist the study was complete and submitted when it wasn't yet? #realitycheck I hope the sent it in late last week but let's see. A press release will come out I would imagine at that time.
Comment by
Trueblood on Jan 03, 2022 9:06am
You would think the clinical rials would be an interactive process between the FDA and Therma. The final results have yet to be submitted to th FDA as per the last press release
Comment by
nrv090909 on Jan 03, 2022 12:34pm
Per Rob's statement, my thoughts are that documents are subbmitted to FDA and we are awaiting the final stamp to proceed. Should be a good month ahead.